cagrisema phase 3 results 2025 obesity cagrilintide semaglutide Novo Nordisk's 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026 Medication Cagrilintide vs Retatrutide for Size:1000 mcg/ml - 30 ml (Pack of 3)
SKU: 30787846656
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20













/assets/images/provider/photos/1922393.jpg)





